Charlie Cao

Charlie Cao serves as the Head of Biometrics at Calico Life Sciences since September 2022, focusing on biometrics support for clinical development in aging-related diseases including CNS and Oncology. Previously held significant roles at Biogen from July 2018 to August 2022, including Executive Director, Head of Biostatistics, where responsibility encompassed global statistical support in drug development. At Takeda, from September 2000 to July 2018, held various senior positions, culminating in Senior Director, Statistics in Medical Affairs, overseeing statistical strategies for medical research. Prior experience includes roles at AbbVie, where statistical responsibilities spanned pharmacokinetics and drug applications. Charlie holds a Ph.D. in Statistics from Duke University and a Master of Science and Bachelor of Science in Applied Mathematical Statistics and Applied Mathematics from Southeast University, respectively.